SciELO - Scientific Electronic Library Online

 
vol.50 número3Comportamiento de los alelos HLA-DQB1*02 y HLA-DQB1*03 en pacientes con diagnóstico presuntivo de enfermedad celíacaLa endocarditis infecciosa sigue desafiando a la clínica moderna índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Cubana de Medicina

versão impressa ISSN 0034-7523

Resumo

ALFONZO GUERRA, Jorge Pablo. Pre-high blood pressure: Myth or reality. Rev cubana med [online]. 2011, vol.50, n.3. ISSN 0034-7523.

The high blood pressure category (figures under 140/90 mm Hg and over 120/180 mm Hg) is suggested by life insurance agencies due to above figures increase the risk to develop high blood pressure, cardiovascular disease and sudden death of cardiovascular origin. In 2003, to classify the high blood pressure, the JNC-7 take up again this term. Epidemiological studies place the prevalence around the 30% in adult population progressing to a HTA established in the 19% of cases each 4 years. It is frequent its association with some risk factor of cardiovascular disease (in subjects aged > 65 in a 42% versus 27% in those normotensive). Due to its high prevalence, its association with other risk factors of cardiovascular disease and the increase of morbidity and mortality from these conditions, compared to those with the "optimal" blood pressure. The high blood pressure is considered as a significant health problem. Many studies support the need to know with accuracy its prevalence and incidence, as well as its treatment with healthy lifestyles and in the cases with a high risk of cardiovascular disease (diabetes, chronic renal disease, proteinuria, heart disease and dyslipemia), with antihypertensive drugs. The objectives of present paper are based on: to reduce the blood pressure figures the nearest from the optimal ones (< 120/180 mm Hg) and to control the risk factors of cardiovascular diseases. The achievements expected with this strategy are: to decrease the blood pressure figures, the development of high blood pressure or to extend its appearance, to avoid the risk of damage in target organ, the number of cardiovascular diseases and to obtain a significant socioeconomic impact in public health. However, there are many question marks due to lack of evidences on the usefulness of its treatment.

Palavras-chave : Pre-higher normal blood pressure.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons